Final dividend Royal DSM
(Thomson Reuters ONE) -
The DSM Annual General Meeting of Shareholders on 11 May 2012 passed a
resolution to declare a dividend for 2011 of ?1.45 per ordinary share of ?1.50
par value. An interim dividend of ?0.45 per ordinary share having been paid on
26 August 2011, the final dividend for 2011 will amount to ?1.00 per ordinary
share. With the passing of the resolution by the AGM, and in line with DSM's
policy to provide a stable and preferably rising dividend, 2011 marks the second
consecutive year DSM's dividend has been increased.
This final dividend of ?1.00 will be paid out in cash or in the form of ordinary
shares at the option of the shareholder. Dividend in cash will be paid after
deduction of 15% Dutch dividend withholding tax. The ex-dividend date on NYSE
Euronext will be 15 May 2012 and the record date will be 17 May 2012.
Shareholders have from 18 May until 1 June 2012 (3.00 pm CET) to indicate their
choice. On 4 June 2012 after the close of trading on NYSE Euronext the number of
dividend rights of ordinary shares entitling the holder to one ordinary share
will be determined.
This exchange ratio will be based on the volume weighted average price of all
ordinary shares in DSM traded at NYSE Euronext on 28 May 2012 up to and
including 1 June 2012. The value of the stock dividend will be virtually equal
to the value of the cash dividend. The ordinary shares that constitute the stock
dividend are entitled to any dividend for the financial year 2012 and to the
dividends for subsequent financial years. Stock dividend rights will not be
traded on NYSE Euronext.
The following timetable applies:
15 May 2012: Ex-dividend quotation
17 May 2012: Record Date
18 May 2012 - 4 June 2012(3.00 pm CET): Period in which shareholders can
indicate their choice
04 June 2012 (COB): Announcement of the
exchange ratio
06 June 2012: Delivery of shares or
cash payment
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
22,000 employees deliver annual net sales of around ?9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com.
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Hans Vossen
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
e-mail media.relations(at)dsm.com e-mail investor.relations(at)dsm.com
Press release-pdf:
http://hugin.info/130663/R/1611439/512614.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1611439]
Unternehmensinformation / Kurzprofil:
Datum: 11.05.2012 - 18:16 Uhr
Sprache: Deutsch
News-ID 145650
Anzahl Zeichen: 4118
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 275 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Final dividend Royal DSM"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
